Home/Filings/4/0001764013-21-000044
4//SEC Filing

Torti Frank 4

Accession 0001764013-21-000044

CIK 0001764013other

Filed

Mar 22, 8:00 PM ET

Accepted

Mar 23, 8:54 AM ET

Size

7.3 KB

Accession

0001764013-21-000044

Insider Transaction Report

Form 4
Period: 2021-03-19
Torti Frank
Director
Transactions
  • Award

    Common Stock

    2021-03-19+19,20047,600 total
  • Award

    Stock Option (right to buy)

    2021-03-19+28,90028,900 total
    Exercise: $17.00Exp: 2031-03-19Common Stock (28,900 underlying)
Footnotes (2)
  • [F1]Represents the number of shares underlying restricted stock unit awards ("RSUs") granted to the Reporting Person pursuant to a non-employee director grant. Each RSU represents the contingent right to receive one share of common stock of the Issuer. The RSUs vest in their entirety one year after the date of grant on March 19, 2022, subject to the Reporting Person's continued service to the Issuer as of such date; provided that the Reporting Person may elect to defer settlement of the RSUs upon vesting, subject to the requirements of Rule 409A.
  • [F2]The shares underlying the options vest one year after the date of grant on March 19, 2022, subject to the Reporting Person's continuous service to the Issuer as of such date.

Issuer

Immunovant, Inc.

CIK 0001764013

Entity typeother

Related Parties

1
  • filerCIK 0001647805

Filing Metadata

Form type
4
Filed
Mar 22, 8:00 PM ET
Accepted
Mar 23, 8:54 AM ET
Size
7.3 KB